Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility-Reference-Cited by-同舟云学术

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

Published:2011-06 Issue:6 Volume:54 Page:1137-1144
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Martin Natasha K.,Vickerman Peter,Foster Graham R.,Hutchinson Sharon J.,Goldberg David J.,Hickman Matthew

Publisher

Elsevier BV

Subject

Hepatology

Reference42 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. ACMD, The primary prevention of hepatitis C among injecting drug users; 2009.

3. Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis;Vickerman;Addiction,2009

4. The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis;Kwon;J Acquir Immune Defic Syndr,2009

5. Hepatitis C infection among injecting drug users in England and Wales 1992–2006: there and back again?;Sweeting;Am J Epidemiol,2009

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco;International Journal of Drug Policy;2024-09

2. Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK;International Journal of Drug Policy;2024-06

3. Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis;eClinicalMedicine;2023-12

4. Hepatitis C: epidemiology, natural history, and diagnosis;Comprehensive Guide to Hepatitis Advances;2023

5. Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico;International Journal of Drug Policy;2022-12